{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:10:47Z","timestamp":1785471047518,"version":"3.56.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.neuropharm.2017.02.003","type":"journal-article","created":{"date-parts":[[2017,2,4]],"date-time":"2017-02-04T22:00:21Z","timestamp":1486245621000},"page":"100-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Involvement of GluN2B subunit containing N-methyl- d -aspartate (NMDA) receptors in mediating the acute and chronic synaptotoxic effects of oligomeric amyloid-beta (A\u03b2) in murine models of Alzheimer's disease (AD)"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1698-4257","authenticated-orcid":false,"given":"Gerhard","family":"Rammes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Mattusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Wulff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Seeser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Kreuzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1868-5082","authenticated-orcid":false,"given":"Kaichuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan M.","family":"Deussing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Herms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris G.","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.02.003_bib1","series-title":"Memantine Reverses SS-amyloid Oligomers-induced Deficits in Long Term Potentiation (LTP) in Murine Hippocampal Slices","author":"Albrecht","year":"2008"},{"key":"10.1016\/j.neuropharm.2017.02.003_bib2","unstructured":"Albrecht, M., Rammes, G., Parsons, C. G., 2009. Memantine reverses \u00df-amyloid oligomers-induced deficits in long term potentiation (LTP) in murine hippocampal slices. Alzheimer\u2019s & Dementia. 13th International Conference on Alzheimer's Disease (ICAD), Vienna, Austria, p. 1847."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib3","first-page":"177","article-title":"\u00dcber eine eigenartige Erkrankung der Hirnrinde","volume":"30","author":"Alzheimer","year":"1907","journal-title":"Cent. fur Nervenheilkd. Psychiatr."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib4","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.0511065103","article-title":"NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK\/MAPK activation","volume":"103","author":"Amadoro","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib5","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1528-1167.2006.00554.x","article-title":"Incidence and predictors of seizures in patients with Alzheimer's disease","volume":"47","author":"Amatniek","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2017.02.003_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0165-0270(01)00374-0","article-title":"The LTP Program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events","volume":"108","author":"Anderson","year":"2001","journal-title":"J.\u00a0Neurosci. Methods"},{"issue":"825","key":"10.1016\/j.neuropharm.2017.02.003_bib7","first-page":"e821","article-title":"Different beta-amyloid oligomer assemblies in Alzheimer brains correlate with age of disease onset and impaired cholinergic activity","volume":"33","author":"Bao","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2017.02.003_bib8","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1471-4159.2005.03407.x","article-title":"Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease","volume":"95","author":"Barghorn","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/archneur.65.4.499","article-title":"Clinical and neuropathological features of the arctic APP gene mutation causing early-onset Alzheimer disease","volume":"65","author":"Basun","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib10","first-page":"11","article-title":"Altered synaptic function in Alzheimer's disease","volume":"545","author":"Bell","year":"2006","journal-title":"Eur. J. Pharmacol. - Mol. Pharmacol. Sect."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib72","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1038\/nprot.2006.312","article-title":"Patch-clamp recording from mossy fiber terminals in hippocampal slices","volume":"1","author":"Bischofberger","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1159\/000116984","article-title":"Staging of Alzheimer-related cortical destruction","volume":"33","author":"Braak","year":"1993","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib12","doi-asserted-by":"crossref","first-page":"8740","DOI":"10.1073\/pnas.1206171109","article-title":"Critical role of soluble amyloid-beta for early hippocampal hyperactivity in a mouse model of Alzheimer's disease","volume":"109","author":"Busche","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib13","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1460-9568.2007.05431.x","article-title":"Maintenance of superior learning and memory function in NR2B transgenic mice during ageing","volume":"25","author":"Cao","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbr.2011.08.024","article-title":"Behavioural and cellular effects of exogenous amyloid-beta peptides in rodents","volume":"225","author":"Chambon","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib15","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1046\/j.1471-4159.1997.69052138.x","article-title":"Molecular dissection of native mammalian forebrain NMDA receptors containing the NR1 C2 exon: direct demonstration of NMDA receptors comprising NR1, NR2A, and NR2B subunits within the same complex","volume":"69","author":"Chazot","year":"1997","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd2896","article-title":"Alzheimer's disease: strategies for disease modification","volume":"9","author":"Citron","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0304-3940(89)90038-4","article-title":"Low-frequence activation of the NMDA receptor system can prevent the induction of LTP","volume":"105","author":"Coan","year":"1989","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib18","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1476-5381.2012.02057.x","article-title":"Alzheimer's disease, beta-amyloid, glutamate, NMDA receptors and memantine\u2013searching for the connections","volume":"167","author":"Danysz","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib19","doi-asserted-by":"crossref","first-page":"12463","DOI":"10.1074\/jbc.R109.080895","article-title":"Calcium signaling and amyloid toxicity in Alzheimer disease","volume":"285","author":"Demuro","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-60761-744-0_11","article-title":"Abeta toxicity in primary cultured neurons","volume":"670","author":"Ferreira","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib21","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.nlm.2011.08.003","article-title":"The Abeta oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease","volume":"96","author":"Ferreira","year":"2011","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib22","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/15216540701283882","article-title":"Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases","volume":"59","author":"Ferreira","year":"2007","journal-title":"IUBMB Life"},{"key":"10.1016\/j.neuropharm.2017.02.003_bib23","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0028-3908(99)00060-X","article-title":"Memantine restores long term potentiation impaired by tonic N-methyl-D-aspartate (NMDA) receptor activation following reduction of Mg2+ in hippocampal slices","volume":"38","author":"Frankiewicz","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.02.003_bib24","doi-asserted-by":"crossref","first-page":"20130136","DOI":"10.1098\/rstb.2013.0136","article-title":"Expression mechanisms underlying long-term potentiation: a postsynaptic view, 10 years on","volume":"369","author":"Granger","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond B Biol. Sci."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nn835","article-title":"Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways","volume":"5","author":"Hardingham","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib26","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2017.02.003_bib27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1471-4159.1996.67010277.x","article-title":"Amyloid beta peptide (25-35) inhibits na+-dependent glutamate uptake in rat hippocampal astrocyte cultures","volume":"67","author":"Harris","year":"1996","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib28","doi-asserted-by":"crossref","first-page":"e64318","DOI":"10.1371\/journal.pone.0064318","article-title":"Inhibitory neuron and hippocampal circuit dysfunction in an aged mouse model of Alzheimer's disease","volume":"8","author":"Hazra","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuropharm.2017.02.003_bib29","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/(SICI)1099-1077(199912)14:8<525::AID-HUP140>3.0.CO;2-T","article-title":"A\u00a0unifying hypothesis of Alzheimer's disease. II. Pathophysiological processes","volume":"14","author":"Heininger","year":"1999","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib30","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/357686a0","article-title":"Developmental regulation of NMDA receptor-mediated synaptic currents at a central synapse","volume":"357","author":"Hestrin","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2017.02.003_bib31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00213-005-2203-9","article-title":"Evidence for improved performance in cognitive tasks following selective NR2B NMDA receptor antagonist pre-treatment in the rat","volume":"179","author":"Higgins","year":"2005","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib32","article-title":"Glutamate receptors in preclinical research on Alzheimer's disease: update on recent advances","author":"Hu","year":"2011","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.neuropharm.2017.02.003_bib33","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1006\/nbdi.2002.0557","article-title":"Long-term potentiation is increased in the CA1 area of the hippocampus of APP(swe\/ind) CRND8 mice","volume":"11","author":"Jolas","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib34","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.neurobiolaging.2009.04.005","article-title":"Protection against Abeta-mediated rapid disruption of synaptic plasticity and memory by memantine","volume":"32","author":"Klyubin","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2017.02.003_bib35","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.neurobiolaging.2006.06.019","article-title":"Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice","volume":"28","author":"Knobloch","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2017.02.003_bib36","doi-asserted-by":"crossref","first-page":"10191","DOI":"10.1523\/JNEUROSCI.3432-04.2004","article-title":"Synaptic targeting by Alzheimer's-related amyloid beta oligomers","volume":"24","author":"Lacor","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib37","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","article-title":"Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease","volume":"27","author":"Lacor","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib38","unstructured":"Lacor, P. N., Renner, M., Velasco, P. T., Triller, A., Klein, W. L., 2008. Single molecule trafficking reveals a new mechanism to explain Abeta oligomer (ADDLs) targeting of synapses and interference with memory-related protein distribution. 38th Society for Neuroscience Annual Meeting, Washington, USA, p. #829.822."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib39","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1523\/JNEUROSCI.17-08-02876.1997","article-title":"Selective alteration of long-term potentiation-induced transcriptional response in hippocampus of aged, memory-impaired rats","volume":"17","author":"Lanahan","year":"1997","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib40","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","article-title":"A\u00a0specific amyloid-beta protein assembly in the brain impairs memory","volume":"440","author":"Lesne","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2017.02.003_bib41","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.neuron.2009.05.012","article-title":"Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake","volume":"62","author":"Li","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2017.02.003_bib42","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1523\/JNEUROSCI.0203-11.2011","article-title":"Soluble A{beta} oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors","volume":"31","author":"Li","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib43","doi-asserted-by":"crossref","first-page":"20130135","DOI":"10.1098\/rstb.2013.0135","article-title":"The expression of long-term potentiation: reconciling the preists and the postivists","volume":"369","author":"Macdougall","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond B Biol. Sci."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib44","doi-asserted-by":"crossref","first-page":"870","DOI":"10.2353\/ajpath.2010.090452","article-title":"Memantine improves cognition and reduces Alzheimer's-like neuropathology in transgenic mice","volume":"176","author":"Martinez-Coria","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib45","doi-asserted-by":"crossref","first-page":"12548","DOI":"10.1074\/jbc.273.20.12548","article-title":"Amyloid protein precursor stimulates excitatory amino acid transport. Implications for roles in neuroprotection and pathogenesis","volume":"273","author":"Masliah","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib46","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0166-2236(93)90009-B","article-title":"\u00df-amyloid precursor protein metabolites and loss of neuronal ca2+ homeostasis in Alzheimer's disease","volume":"16","author":"Mattson","year":"1993","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0006-8993(93)90295-X","article-title":"Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF","volume":"621","author":"Mattson","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib48","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1523\/JNEUROSCI.5215-08.2009","article-title":"Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy","volume":"29","author":"Minkeviciene","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib49","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1476-5381.2009.00304.x","article-title":"Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential","volume":"157","author":"Mony","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/hipo.450030106","article-title":"Hippocampal plasticity induced by primed burst, but not long-term potentiation, stimulation is impaired in area CA1 of aged Fischer 344 rats","volume":"3","author":"Moore","year":"1993","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2017.02.003_bib51","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/14640748608401615","article-title":"The memory deficits in Alzheimer-type dementia: a review","volume":"38","author":"Morris","year":"1986","journal-title":"Q.\u00a0J. Exp. Psychol. A"},{"key":"10.1016\/j.neuropharm.2017.02.003_bib52","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","article-title":"High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation","volume":"20","author":"Mucke","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib53","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S0306-4522(99)00036-6","article-title":"Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide","volume":"92","author":"Noda","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.02.003_bib73","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neurobiolaging.2003.08.012","article-title":"Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease","volume":"24","author":"Oddo","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2017.02.003_bib54","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.neuron.2007.07.025","article-title":"Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease","volume":"55","author":"Palop","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2017.02.003_bib55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.expneurol.2007.10.008","article-title":"Amyloid beta peptides and glutamatergic synaptic dysregulation","volume":"210","author":"Parameshwaran","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib56","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neuropharm.2007.07.013","article-title":"Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse","volume":"53","author":"Parsons","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.02.003_bib57","doi-asserted-by":"crossref","first-page":"14537","DOI":"10.1523\/JNEUROSCI.2692-08.2008","article-title":"Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus","volume":"28","author":"Puzzo","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib58","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.neuropharm.2011.01.051","article-title":"Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of beta-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices","volume":"60","author":"Rammes","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.02.003_bib59","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neuron.2010.04.029","article-title":"Deleterious effects of amyloid beta oligomers acting as an extracellular scaffold for mGluR5","volume":"66","author":"Renner","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2017.02.003_bib60","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.neurobiolaging.2010.01.011","article-title":"Early neuronal dysfunction by amyloid beta oligomers depends on activation of NR2B-containing NMDA receptors","volume":"32","author":"Ronicke","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2017.02.003_bib61","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbr.2008.02.016","article-title":"Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior","volume":"192","author":"Selkoe","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib62","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib74","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fncir.2012.00064","article-title":"Entorhinal theta-frequency input to the dentate gyrus trisynaptically evokes hippocampal CA1 LTP","volume":"6","author":"Stepan","year":"2012","journal-title":"Front. Neural Circuits"},{"key":"10.1016\/j.neuropharm.2017.02.003_bib63","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/43432","article-title":"Genetic enhancement of learning and memory in mice","volume":"401","author":"Tang","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2017.02.003_bib75","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1113\/jphysiol.2005.103754","article-title":"Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers","volume":"572","author":"Townsend","year":"2006","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib64","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ana.20101","article-title":"Progressive age-related development of Alzheimer-like pathology in APP\/PS1 mice","volume":"55","author":"Trinchese","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib76","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.neuron.2008.09.039","article-title":"Contribution of hippocampal and extra-hippocampal NR2B-containing NMDA receptors to performance on spatial learning tasks","volume":"60","author":"von Engelhardt","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2017.02.003_bib65","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in\u00a0vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2017.02.003_bib66","doi-asserted-by":"crossref","first-page":"e15709","DOI":"10.1371\/journal.pone.0015709","article-title":"The concentration of soluble extracellular amyloid-beta protein in acute brain slices from CRND8 mice","volume":"5","author":"Waters","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2017.02.003_bib67","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s10571-011-9691-4","article-title":"Abeta oligomer-induced synapse degeneration in Alzheimer's disease","volume":"31","author":"Wilcox","year":"2011","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib68","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2147\/NDT.S7460","article-title":"Brain amyloid beta protein and memory disruption in Alzheimer's disease","volume":"6","author":"Xia","year":"2010","journal-title":"Neuropsychiatry Dis. Treat."},{"key":"10.1016\/j.neuropharm.2017.02.003_bib69","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0896-6273(00)80115-4","article-title":"Mechanisms of neuronal degeneration in Alzheimer's disease","volume":"16","author":"Yankner","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2017.02.003_bib70","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.neuropharm.2008.07.046","article-title":"Regulation of NMDA receptor subunit expression and its implications for LTD, LTP, and metaplasticity","volume":"55","author":"Yashiro","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.02.003_bib71","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0028-3908(97)00070-1","article-title":"Uncompetitive NMDA receptor antagonists attenuate NMDA-induced impairment of passive avoidance learning and LTP","volume":"36","author":"Zajaczkowski","year":"1997","journal-title":"Neuropharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817300448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817300448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T01:53:09Z","timestamp":1533865989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817300448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":76,"alternative-id":["S0028390817300448"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.02.003","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of GluN2B subunit containing N-methyl-d-aspartate (NMDA) receptors in mediating the acute and chronic synaptotoxic effects of oligomeric amyloid-beta (A\u03b2) in murine models of Alzheimer's disease (AD)","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}